Adamax
Adamax is a synthetic peptide described by suppliers as a derivative of Semax. Semax belongs to the analogues of the ACTH(4-10) fragment of adrenocorticotropic hormone (Ashmarin, 2001).
What do studies tell us?
We found no peer-reviewed studies on Adamax itself in PubMed (search of 12 October 2026). Descriptions of its effects online repeat data on Semax. Those data cannot be transferred to another molecule without separate studies. Semax and its derivatives are covered in more detail in our review Semax peptide: mechanism and evidence.
Legal and anti-doping status
Adamax has no approval for human use, and the 2026 WADA Prohibited List does not name it. Even so, it falls under class S0 (non-approved substances), prohibited at all times.
Adamax in the Endogenic catalogue
The catalogue includes Adamax 10mg in a vial and Adamax spray. Each of these items is a chemical reagent intended exclusively for laboratory research (Research Use Only). It is not a medicinal product, dietary supplement or food. It is not intended for use in humans or animals.
Sources:
Ashmarin IP. [Anticipated and unexpected physiological effects of oligopeptides (glyprolines, ACTH (4-10) analogs, taftsin, and thyroliberin)]. Ross Fiziol Zh Im I M Sechenova. 2001;87(11):1471-6. PMID: 11816278
World Anti-Doping Agency. The 2026 Prohibited List. In force from 1 January 2026.